US Patent 8003128 Polylactide nanoparticles

Patent 8003128 was granted and assigned to LTS Lohmann Therapie-Systeme AG on August, 2011 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Current Assignee

LTS Lohmann Therapie-Systeme AG

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

8003128

Date of Patent

August 23, 2011

Patent Application Number

12225555

Date Filed

March 13, 2007

Patent Primary Examiner

‌

Robert A Wax

Patent abstract

A drug targeting system for administering a pharmacologically active substance to the central nervous system of a mammal across the animal's blood brain barrier. The drug targeting system comprises nanoparticles made of poly(DL-lactide) and/or poly(DL-lactide-co-glycolide), a pharmacologically active substance which is absorbed to, adsorbed to, and/or incorporated into the nanoparticles, and either contains TPGS or comprises a pluronic 188 surfactant coating deposited on the drug-loaded nanoparticles.